Related Experiment Video
Updated: Jul 20, 2026

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
Gbetagamma that interacts with adenylyl cyclase in opioid tolerance originates from a Gs protein
Hoau-Yan Wang1, Lindsay H Burns
1Department of Physiology and Pharmacology, City University of New York Medical School, 138th Street and Convent Avenue, New York, New York 10031, USA. hywang@sci.ccny.cuny.edu
Abstract:
We previously demonstrated that chronic morphine induces a change in G protein coupling by the mu opioid receptor (MOR) from Gi/o to Gs, concurrent with the instatement of an interaction between Gbetagamma and adenylyl cyclase types II and IV. These two signaling changes confer excitatory effects on the cell in place of the typical inhibition by opioids and are associated with morphine tolerance and dependence. Both signaling changes and these behavioral manifestations of chronic morphine are attenuated by cotreatment with ultra-low-dose naloxone. In the present work, using striatum from chronic morphine-treated rats, we isotyped the Gbeta within Gs and Go heterotrimers that coupled to MOR and compared these to the Gbeta isotype of the Gbetagamma that interacted with adenylyl cyclase II or IV after chronic morphine treatment. Isotyping results show that chronic morphine causes a Gs heterotrimer associated with MOR to release its Gbetagamma to interact with adenylyl cyclase. These data suggest that the switch to Gs coupling by MOR in response to chronic morphine, which is attenuated by ultra-low-dose opioid antagonist cotreatment, leads to a two-pronged stimulation of adenylyl cyclase utilizing both Galpha and Gbetagamma subunits of the Gs protein novel to this receptor.
Insights
Chronic morphine alters mu opioid receptor (MOR) signaling, switching from Gi/o to Gs proteins. This switch, involving Gbetagamma subunits, contributes to morphine tolerance and dependence.
Area of Science:
- Neuropharmacology
- Molecular Biology
- Cellular Signaling
Background:
- Chronic morphine administration alters mu opioid receptor (MOR) G protein coupling from Gi/o to Gs.
- This signaling shift is linked to excitatory cellular effects, morphine tolerance, and dependence.
- Ultra-low-dose naloxone can attenuate these morphine-induced signaling and behavioral changes.
Purpose of the Study:
- To investigate the specific Gbeta isotypes involved in MOR G protein coupling after chronic morphine treatment.
- To compare the Gbeta isotypes within Gs and Go heterotrimers coupled to MOR with those interacting with adenylyl cyclase II and IV.
- To elucidate the mechanism by which MOR signaling shifts to Gs and its role in morphine's effects.
Main Methods:
- Utilizing striatal tissue from rats subjected to chronic morphine treatment.
- Employing G protein isotyping techniques to identify Gbeta subunits.
- Analyzing the interaction of Gbetagamma subunits with adenylyl cyclase types II and IV.
Main Results:
- Chronic morphine treatment causes a Gs heterotrimer associated with MOR to release its Gbetagamma subunit.
- This released Gbetagamma subunit subsequently interacts with adenylyl cyclase.
- The study identified specific Gbeta isotypes involved in these altered signaling pathways.
Conclusions:
- The switch in MOR coupling to Gs proteins in response to chronic morphine involves the release of Gbetagamma subunits.
- This released Gbetagamma interacts with adenylyl cyclase, contributing to a dual activation pathway.
- These findings suggest a novel mechanism for MOR signaling that underlies morphine tolerance and dependence, which can be modulated by ultra-low-dose naloxone.
More Related Videos
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Two...
Opioid Receptors: Overview
Activation and Inactivation of G Proteins
GPCR Desensitization
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...

